首页> 美国卫生研究院文献>Cardiovascular Diseases >Percutaneous Closure of Window-Type Patent Ductus Arteriosus Using the CardioSEAL® and STARFlex® Devices
【2h】

Percutaneous Closure of Window-Type Patent Ductus Arteriosus Using the CardioSEAL® and STARFlex® Devices

机译:使用CardioSEAL®和STARFlex®设备经皮封闭窗口型动脉导管未闭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Transcatheter closure of patent ductus arteriosus is routinely performed using various devices. After the withdrawal of the Rashkind umbrella device from the market, the wide window-type patent ductus arteriosus has been difficult to close percutaneously. Two patients with this condition are presented: a 17-year-old man and a 62-year-old woman with short (4.5- and 5.2-mm-diameter, respectively) ductus. We successfully implanted a 17-mm CardioSEAL® device in the 1st patient and a 23-mm STARFle® in the 2nd, with no residual shunt at follow-up (22 and 8 months, respectively). Although these devices (which follow the general design of the Rashkind umbrella) are usually applied to atrial septal defect closure, we believe that CardioSEAL and STARFlex implants could be the treatment of choice in percutaneous treatment of window-type patent ductus arteriosus. >(Tex Heart Inst J 2003;30:236–9)
机译:通常使用各种装置进行动脉导管未闭的经导管闭合。在Rashkind雨伞装置退出市场后,宽窗口型动脉导管未闭很难经皮闭合。介绍了两名患有这种情况的患者:一名17岁的男性和一名62岁的女性,其导管较短(直径分别为4.5和5.2毫米)。我们成功地在第一位患者中植入了17毫米CardioSEAL®设备,在第二位患者中成功植入了23毫米STARFle®,并且在随访时(分别为22和8个月)没有残留分流。尽管这些设备(遵循Rashkind伞的总体设计)通常用于闭合房间隔缺损,但我们认为CardioSEAL和STARFlex植入物可能是经皮治疗窗型动脉导管未闭的治疗选择。 >(Tex Heart Inst J 2003; 30:236–9)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号